Cohort 1 | Cohort 2 | Cohort 3 | Cohort 4 | Total | |
---|---|---|---|---|---|
(n = 6) | (n = 6) | (n = 6) | (n = 6) | (N = 24) | |
Participants with one or more adverse event | 6 (100.0) | 6 (100.0) | 3 (50.0) | 4 (66.7) | 19 (79.2) |
Headache | 3 (50.0) | 5 (83.3) | 2 (33.3) | 2 (33.3) | 12 (50.0) |
Back pain | 1 (16.7) | 2 (33.3) | 1 (16.7) | 3 (50.0) | 7 (29.2) |
Catheter site pain | 2 (33.3) | 0 | 1 (16.7) | 0 | 3 (12.5) |
Dizziness postural | 0 | 1 (16.7) | 0 | 1 (16.7) | 2 (8.3) |
Hypoesthesia | 1 (16.7) | 0 | 1 (16.7) | 0 | 2 (8.3) |
Pain in extremity | 1 (16.7) | 0 | 1 (16.7) | 0 | 2 (8.3) |
Nausea | 0 | 1 (16.7) | 1 (16.7) | 0 | 2 (8.3) |
Musculoskeletal stiffness | 0 | 1 (16.7) | 0 | 0 | 1 (4.2) |
Neck pain | 0 | 0 | 1 (16.7) | 0 | 1 (4.2) |
Gastroesophageal reflux disease | 0 | 0 | 1 (16.7) | 0 | 1 (4.2) |
Regurgitation | 0 | 0 | 0 | 1 (16.7) | 1 (4.2) |
Toothache | 0 | 0 | 0 | 1 (16.7) | 1 (4.2) |
Dermatophytosis | 0 | 0 | 1 (16.7) | 0 | 1 (4.2) |
Sinusitis | 0 | 0 | 0 | 1 (16.7) | 1 (4.2) |
Post lumbar puncture syndrome | 0 | 1 (16.7) | 0 | 0 | 1 (4.2) |
Pruritus | 1 (16.7) | 0 | 0 | 0 | 1 (4.2) |
Flushing | 0 | 1 (16.7) | 0 | 0 | 1 (4.2) |